Skip to main content

To Switch or Not: Biosimilars in Inflammatory Arthritis

Dr. Jonathan Kay reports on abstract 1112 at ACR22 Convergence.

ADD THE FIRST COMMENT

If you are a health practitioner, you may to comment.

Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.